Blog
RSS FeedPosted by Michael Wonder on 07 Nov 2019
Brexit: what it could mean for drug prices
5 November 2019 - Trading away the UK’s rights to drive down drug prices could cost the NHS half a ...
Posted by Michael Wonder on 06 Nov 2019
Corbyn accuses Tories of planning deal to hike drug prices with Trump as election looms
5 November 2019 - Drug prices have become an issue in the UK’s general election, after Labour leader Jeremy Corbyn ...
Posted by Michael Wonder on 29 Oct 2019
NHS bill for US drugs 'could soar under post-Brexit trade deal'
28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...
Posted by Michael Wonder on 29 Oct 2019
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks
29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...
Posted by Michael Wonder on 05 Oct 2019
Drug pricing: Could Labour’s “radical” plan work?
4 October 2019 - A necessary reform or a threat to research? ...
Posted by Michael Wonder on 03 Oct 2019
Drug firms 'colluded' to overcharge NHS by up to 1,800%
3 October 2019 - Three drug manufactures broke competition law by colluding to illegally boost the price of a vital ...
Posted by Michael Wonder on 27 Sep 2019
Industry shoots down Labour's plans to tackle 'extortionate' drug prices
26 September 2019 - Labour's promise to “take on pharmaceutical companies” which “deny life-saving and life-changing medicines to ill patients ...
Posted by Michael Wonder on 22 Aug 2019
ABPI position on US trade deal and medicines pricing
21 August 2019 - In response to concerns about the impact a US trade deal would have on medicine pricing, ...
Posted by Michael Wonder on 14 Aug 2019
Drug company Aspen may pay NHS £8 million after investigation alleges illegal deal to hike drug price
14 August 2019 - The drug company Aspen may have to pay the NHS £8 million (€8.7 million ; $9.7 ...
Posted by Michael Wonder on 12 Aug 2019
Drug maker 'will make $21 billion from treating cystic fibrosis'
12 August 2019 - Vertex is accused of raking in vast profits while making Orkambi unaffordable to NHS. ...
Posted by Michael Wonder on 12 Aug 2019
Is rate of return pricing a useful approach when value based pricing is not appropriate?
12 August 2019 - The pricing of new health technologies, such as drugs or devices, involves deciding how the economic ...
Posted by Michael Wonder on 28 May 2019
UK refuses to back 'game-changing' resolution on drug pricing
28 May 2019 - Global agreement urges governments to share information on actual cost of medicines, with aim of making them ...
Posted by Michael Wonder on 21 May 2019
The global battle over high drug prices
21 May 2019 - Western countries, as well as poor ones, are demanding transparency in the cost of drugs. ...
Posted by Michael Wonder on 13 May 2019
The UK’s new medicines pricing deal – opportunities and risks for pharma
10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access ...
Posted by Michael Wonder on 01 May 2019
Drug maker Takeda to introduce value-based pricing in Europe
29 April 2019 - Japanese company to refund Crohn's disease patients with no improvements. ...